ArticleCancer2017

Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

Satoshi Okazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.